Avenzo Therapeutics
Scott Lipman is the Senior Vice President of Corporate Development at Avenzo Therapeutics. Scott previously held roles at leading companies like Bristol Myers Squibb, Turning Point Therapeutics, and Goldman Sachs, where Scott gained extensive experience in business development, strategy, and finance. With a background in Chemical Engineering and an MBA from Northwestern University, Scott has been involved in multi-billion dollar transactions and collaborations within the healthcare industry. With a strong track record in transactional experience and strategic planning, Scott is a valuable asset to any organization.